Literature DB >> 27790417

The Effects of Dietary Supplements of Calcium, Vitamin D and Estrogen Hormone on Serum Levels of OPG and RANKL Cytokines and their Relationship with Increased Bone Density in Rats.

Fatemeh Piri1, Afra Khosravi2, Ardeshir Moayeri3, Ayat Moradipour4, Siamak Derakhshan5.   

Abstract

INTRODUCTION: Osteoprotegerin (OPG)-Receptor activator of nuclear factor kappa-B ligand (RANKL) pathway is one of the contributing factors in the regulation of osteogenesis and bone resorption routes. AIM: The purpose of this study was to evaluate the effects of various dietary supplements on this pathway.
MATERIALS AND METHODS: The samples for this study (24 newborn rats) were divided in three groups according to the experiment applied for each group. Rats were given special diet according to their group plan for six weeks. Blood samples were collected to measure their serum levels of OPG and RANKL and all organs of rats were used to measure their bone density too. The results were analysed using appropriate statistical analysing tests.
RESULTS: Levels of whole-body bone mineral density in calcium plus vitamin D plus Estrogen (Ca + D + E) group and calcium plus vitamin D (Ca + D) group were significantly increased compared to control group. Mineral density was highest in calcium plus vitamin D plus Estrogen group and was about 0.1357 g/cm2. RANKL had a significant decrease in calcium plus vitamin D plus Estrogen group compared to control and calcium plus vitamin D groups. There was a significant increase in the mean calcium and OPG in both experimental groups rather than control. Also, significant increase in estrogen was observed in Ca + D group than the control group.
CONCLUSION: The results showed that intake of calcium and vitamin D and estrogen at determined dose led to an increase in OPG and RANKL cytokines reduction which ultimately led to an increase in bone mineral density. But Ca, D and E synergies were more effective in increasing bone mineral density compared to only the use of Ca and D.

Entities:  

Keywords:  Estradiol; Osteoblast; Osteoclast

Year:  2016        PMID: 27790417      PMCID: PMC5071917          DOI: 10.7860/JCDR/2016/18648.8433

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

Review 1.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 2.  Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials.

Authors:  Tania Winzenberg; Kelly Shaw; Jayne Fryer; Graeme Jones
Journal:  BMJ       Date:  2006-09-15

Review 3.  Osteoblasts and bone formation.

Authors:  Joana Caetano-Lopes; Helena Canhão; João Eurico Fonseca
Journal:  Acta Reumatol Port       Date:  2007 Apr-Jun       Impact factor: 1.290

4.  The RANKL/RANK/OPG pathway.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

5.  Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.

Authors:  Susan A Krum; Gustavo A Miranda-Carboni; Peter V Hauschka; Jason S Carroll; Timothy F Lane; Leonard P Freedman; Myles Brown
Journal:  EMBO J       Date:  2008-01-24       Impact factor: 11.598

6.  Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.

Authors:  Jung Gu Kim; Jung Hwa Kim; Ja Yeon Kim; Seung Yup Ku; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Young Min Choi
Journal:  Menopause       Date:  2007 Sep-Oct       Impact factor: 2.953

7.  The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

Authors:  Anna Stern; Gail A Laughlin; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  Eur J Endocrinol       Date:  2007-05       Impact factor: 6.664

8.  The relationship of calcium intake and exercise to osteoporosis health beliefs in postmenopausal women.

Authors:  Rachelle A Swaim; Jamie C Barner; Carolyn M Brown
Journal:  Res Social Adm Pharm       Date:  2008-06

Review 9.  Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.

Authors:  R Keith McCormick
Journal:  Altern Med Rev       Date:  2007-06

Review 10.  Biology of RANK, RANKL, and osteoprotegerin.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  5 in total

1.  Protective effect of the olive hydroalcoholic extract on estrogen deficiency-induced bone loss in rats in comparison with estradiol.

Authors:  Farhad Koohpeyma; Mohammad Hossein Dabbaghmanesh; Mehrdokht Hajihoseini; Pedram Talezadeh; Nima Montazeri-Najafabady; Marzieh Bakhshayeshkaram
Journal:  Avicenna J Phytomed       Date:  2020 Nov-Dec

2.  High calcium diet alleviates 5/6 nephrectomy-induced bone deteriorations of lumbar vertebrae in mice.

Authors:  Hai-Tao Hou; Ya-Nan Wang; Shi-Ze Shao; Song Fu; Xiang-Peng Huang; Xiao-Hui Wang
Journal:  Exp Ther Med       Date:  2018-02-14       Impact factor: 2.447

Review 3.  Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland-Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies-2018 Update.

Authors:  Agnieszka Rusińska; Paweł Płudowski; Mieczysław Walczak; Maria K Borszewska-Kornacka; Artur Bossowski; Danuta Chlebna-Sokół; Justyna Czech-Kowalska; Anna Dobrzańska; Edward Franek; Ewa Helwich; Teresa Jackowska; Maria A Kalina; Jerzy Konstantynowicz; Janusz Książyk; Andrzej Lewiński; Jacek Łukaszkiewicz; Ewa Marcinowska-Suchowierska; Artur Mazur; Izabela Michałus; Jarosław Peregud-Pogorzelski; Hanna Romanowska; Marek Ruchała; Piotr Socha; Mieczysław Szalecki; Mirosław Wielgoś; Danuta Zwolińska; Arkadiusz Zygmunt
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-31       Impact factor: 5.555

4.  Calcium Bioavailability of Opuntia ficus-indica Cladodes in an Ovariectomized Rat Model of Postmenopausal Bone Loss.

Authors:  Michelle Quintero-García; Elsa Gutiérrez-Cortez; Alejandra Rojas-Molina; Monsserrat Mendoza-Ávila; Alicia Del Real; Efraín Rubio; Daniel Jiménez-Mendoza; Isela Rojas-Molina
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

5.  Lower Serum Irisin Levels Are Associated with Increased Osteoporosis and Oxidative Stress in Postmenopausal.

Authors:  Ali Badr Roomi; Wassan Nori; Roaa Mokram Hamed
Journal:  Rep Biochem Mol Biol       Date:  2021-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.